Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

Ahmad Ghorab; Aref Al-Kali; Michelle Elliot; Naseema Gangat; Hasan Alkhateeb; Mithun Shah; Yuanhang Liu; Cecilia Arana Yi; Hemant Murthy; Mohamed Kharfan-Dabaja; Ayalew Tefferi; Mrinal Patnaik; Mark Litzow; Talha Badar

doi:10.1038/s41408-022-00691-9

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

Ahmad Ghorab, Aref Al-Kali, Michelle Elliot, Naseema Gangat, Hasan Alkhateeb, Mithun Shah, Yuanhang Liu, Cecilia Arana Yi, Hemant Murthy, Mohamed Kharfan-Dabaja, Ayalew Tefferi, Mrinal Patnaik, Mark Litzow, Talha Badar

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	93
Journal	Blood cancer journal
Volume	12
Issue number	6
DOIs	https://doi.org/10.1038/s41408-022-00691-9
State	Published - Jun 2022

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-022-00691-9

Cite this

Ghorab, A., Al-Kali, A., Elliot, M., Gangat, N., Alkhateeb, H., Shah, M., Liu, Y., Yi, C. A., Murthy, H., Kharfan-Dabaja, M., Tefferi, A., Patnaik, M., Litzow, M., & Badar, T. (2022). Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs. Blood cancer journal, 12(6), Article 93. https://doi.org/10.1038/s41408-022-00691-9

Ghorab, A, Al-Kali, A, Elliot, M, Gangat, N, Alkhateeb, H, Shah, M, Liu, Y, Yi, CA, Murthy, H, Kharfan-Dabaja, M, Tefferi, A , Patnaik, M , Litzow, M & Badar, T 2022, 'Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs', Blood cancer journal, vol. 12, no. 6, 93. https://doi.org/10.1038/s41408-022-00691-9

@article{e972fe4e0d494b7b82604b6315850253,

title = "Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs",

author = "Ahmad Ghorab and Aref Al-Kali and Michelle Elliot and Naseema Gangat and Hasan Alkhateeb and Mithun Shah and Yuanhang Liu and Yi, {Cecilia Arana} and Hemant Murthy and Mohamed Kharfan-Dabaja and Ayalew Tefferi and Mrinal Patnaik and Mark Litzow and Talha Badar",

note = "Funding Information: No relevant conflict of interest to disclose.",

year = "2022",

month = jun,

doi = "10.1038/s41408-022-00691-9",

language = "English (US)",

volume = "12",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies

T2 - continued challenges and unmet needs

AU - Ghorab, Ahmad

AU - Al-Kali, Aref

AU - Elliot, Michelle

AU - Gangat, Naseema

AU - Alkhateeb, Hasan

AU - Shah, Mithun

AU - Liu, Yuanhang

AU - Yi, Cecilia Arana

AU - Murthy, Hemant

AU - Kharfan-Dabaja, Mohamed

AU - Tefferi, Ayalew

AU - Patnaik, Mrinal

AU - Litzow, Mark

AU - Badar, Talha

N1 - Funding Information: No relevant conflict of interest to disclose.

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85133003863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133003863&partnerID=8YFLogxK

U2 - 10.1038/s41408-022-00691-9

DO - 10.1038/s41408-022-00691-9

M3 - Letter

C2 - 35750664

AN - SCOPUS:85133003863

SN - 2044-5385

VL - 12

JO - Blood cancer journal

JF - Blood cancer journal

IS - 6

M1 - 93

ER -

Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this